COM:TWISTBIOSCIENCE
Twist Bioscience
- Stock
Last Close
41.66
22/11 21:00
Market Cap
2.51B
Beta: -
Volume Today
716.37K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Sep '16 | Sep '17 | Sep '18 | Sep '19 | Sep '20 | Sep '21 | Sep '22 | Sep '23 | Sep '24 | ||
---|---|---|---|---|---|---|---|---|---|---|
revenue | 2.27M - | 10.77M 374.53% | 25.43M 136.16% | 54.38M 113.89% | 90.10M 65.67% | 132.33M 46.87% | 203.56M 53.83% | 245.11M 20.41% | 312.97M 27.69% | |
cost of revenue | 9.42M - | 24.02M 154.96% | 32.19M 34.01% | 47.43M 47.34% | 61.41M 29.48% | 80.62M 31.29% | 119.33M 48.02% | 155.38M 30.21% | 179.63M 15.60% | |
gross profit | -7.15M - | -13.25M 85.30% | -6.76M 48.98% | 6.96M 202.91% | 28.69M 312.33% | 51.71M 80.22% | 84.23M 62.89% | 89.73M 6.52% | 133.35M 48.61% | |
selling and marketing expenses | ||||||||||
general and administrative expenses | ||||||||||
selling general and administrative expenses | 18.27M - | 26.06M 42.61% | 43.45M 66.73% | 80.13M 84.41% | 103.27M 28.88% | 135.90M 31.60% | 212.95M 56.69% | 189.74M 10.90% | 218.40M 15.11% | |
research and development expenses | 18.23M - | 19.17M 5.15% | 20.35M 6.15% | 35.68M 75.37% | 43.01M 20.52% | 69.07M 60.61% | 120.31M 74.18% | 106.89M 11.15% | 90.85M 15.01% | |
other expenses | 73K - | -55K 175.34% | -121K 120% | -265K 119.01% | -182K 31.32% | -1.37M 652.75% | -1.09M 20.66% | -667K 38.64% | 44.93M 6,836.13% | |
cost and expenses | 45.92M - | 69.25M 50.79% | 95.99M 38.61% | 163.24M 70.06% | 207.68M 27.23% | 285.59M 37.52% | 452.59M 58.47% | 452.01M 0.13% | 533.80M 18.10% | |
operating expenses | 36.50M - | 45.23M 23.90% | 63.80M 41.05% | 115.81M 81.53% | 146.27M 26.31% | 204.97M 40.13% | 333.26M 62.59% | 296.63M 10.99% | 354.18M 19.40% | |
interest expense | 746K - | 905K 21.31% | 1.31M 45.08% | 1.29M 1.45% | 787K 39.18% | 367K 53.37% | 80K 78.20% | 5K 93.75% | 29K 480% | |
ebitda | -39.11M - | -53.10M 35.77% | -63.95M 20.43% | -106.08M 65.87% | -116.26M 9.60% | -154.19M 32.63% | -247.05M 60.22% | -193.21M 21.79% | -176.71M 8.54% | |
operating income | -43.66M - | -58.48M 33.96% | -70.56M 20.65% | -108.85M 54.27% | -117.58M 8.02% | -153.26M 30.35% | -249.02M 62.48% | -217.16M 12.79% | -220.83M 1.69% | |
depreciation and amortization | 4.23M - | 5.02M 18.73% | 5.73M 14.06% | 2.77M 51.69% | 1.32M 52.40% | -935K 170.99% | 1.98M 311.23% | 23.95M 1,112.86% | 31.43M 31.22% | |
total other income expenses net | 73K - | -55K 175.34% | -121K 120% | 1.47M 1,317.36% | -21.97M 1,591.51% | -768K 96.50% | 20.75M 2,801.43% | -10.92M 152.65% | 12.66M 215.95% | |
income before tax | -44.09M - | -59.03M 33.89% | -70.99M 20.27% | -107.38M 51.25% | -139.55M 29.96% | -154.03M 10.38% | -228.27M 48.20% | -203.47M 10.87% | -208.17M 2.31% | |
income tax expense | 819K - | 280K 65.81% | 242K 13.57% | 292K 20.66% | 382K 30.82% | -1.93M 605.24% | -10.41M 439.43% | 1.15M 111.07% | 560K 51.39% | |
net income | -44.09M - | -59.31M 34.53% | -71.24M 20.11% | -107.67M 51.14% | -139.93M 29.96% | -152.10M 8.69% | -217.86M 43.24% | -204.62M 6.08% | -208.73M 2.01% | |
weighted average shs out | 18.78M - | 18.78M 0% | 26.61M 41.69% | 27.46M 3.20% | 39.19M 42.71% | 48.25M 23.12% | 53.88M 11.68% | 56.88M 5.57% | 58.02M 1.99% | |
weighted average shs out dil | 18.78M - | 18.78M 0% | 26.61M 41.69% | 27.46M 3.20% | 39.19M 42.71% | 48.25M 23.12% | 53.88M 11.68% | 56.88M 5.57% | 58.02M 1.99% | |
eps | -2.35 - | -3.16 34.47% | -2.68 15.19% | -3.92 46.27% | -3.57 8.93% | -3.15 11.76% | -4.04 28.25% | -3.60 10.89% | -3.60 0% | |
epsdiluted | -2.35 - | -3.16 34.47% | -2.68 15.19% | -3.92 46.27% | -3.57 8.93% | -3.15 11.76% | -4.04 28.25% | -3.60 10.89% | -3.60 0% |
All numbers in (except ratios and percentages)